EULAR: Certolizumab Effects Durable at 4 Years in SpA (CME/CE)

(MedPage Today) -- Efficacy seen for both radiographic and nonradiographic axial spondyloarthritis
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Geriatrics | Radiography